Want to create an interactive transcript for this episode?
Podcast: Surfing the MASH Tsunami
Episode: S3-E25.2 - NASH Drug Development In 2022: A Wealth of Data and a Promising NASH Pipeline
Description: This conversation is part of a broader overview of NASH drug development in 2022, led by Stephen Harrison and Jörn Schattenberg.It starts with Jörn commenting on the exceptional scope of opportunities for deep data dives and new learning, which becomes a lead-in for him to ask Stephen about the scope of data available from Intercept. From there, the group explores a range of issues the data might address. Among the key points: safety and tolerability are extremely important to FDA, the idea that the optimal NASH drug will also have an impact on the range of...